FDA Brief

Company record

Remel, Inc

0 FDA warning letters since 2023 and 5 recalls in the last 12 months.

Get an email the day FDA posts anything new about Remel, Inc.

Recalls

ReportedClassFirmProduct and reason
Nov 11 Class II Remel, Inc
Device
Yeastone Broth, 11ML, 10/BOX, used in antibiotic susceptibility testing of mycological clinical specimens
Affected lot did not meet specifications. Product may report false susceptibility to antifungal agents, specifically within the Azole family.
Jul 8 Class II Remel, Inc
Device
GC Agar Base (150mm) 10/PK R04030; GC Agar Base (100mm) 10/PK R01460
Reduced or no recovery of some strains of Neisseria gonorrhoeae.
Apr 22 Class II Remel, Inc
Device
Yeastone Broth, 11ML, 10/BOX YY3462
Products may report incorrect AST results during quality control. Health consequences may include delayed response or the need to change to another antifungal agent if laboratory ignores Quality Control test result.
Mar 4 Class II Remel, Inc
Device
Campy CVA Medium 100/PK, R01272
Customer complaints report low to no recovery of Campylobacter Jejuni ATCC 33291 on identified lot of medium.
Dec 3, 2025 Class II Remel, Inc
Device
1. CAMHB W/LHB, MANUAL, 11ML, 10/BOX YCP112-10 2. BRUCELLA BROTH, 11ML, 10/BOX YT3450
Products may contain contamination, which may result in a darker or brown media color.